Market Cap 116.10M
Revenue (ttm) 27.47M
Net Income (ttm) -26.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.83%
Debt to Equity Ratio 0.00
Volume 270,200
Avg Vol 154,336
Day's Range N/A - N/A
Shares Out 4.20M
Stochastic %K 14%
Beta 2.47
Analysts Strong Sell
Price Target $98.39

Company Profile

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is adv...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 949 2680
Address:
40 Guest Street, Boston, United States
daprinta
daprinta Aug. 18 at 7:48 PM
$CUE been nibbling on more stocks on dips in this $25 range…story is status quo…the rip will be worth owning & this will move like it’s hairs on fire
0 · Reply
Relee187200
Relee187200 Aug. 18 at 3:38 PM
$CUE Pitiful
0 · Reply
tealeaves
tealeaves Aug. 17 at 6:26 PM
$CUE today’s decline is consistent with profit-taking + anticipation of PIPE-share liquidity + low-float volatility than with deterioration in the underlying clinical story. The CEO transaction may add some headline pressure, but because it was tax-related, I consider it secondary to the 1.5M-share resale registration from July’s $50M PIPE (cost basis of which was $33.21/share). I’ll add to my position on dips below $25.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 14 at 8:14 PM
$CUE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$24.14 down -804.12% YoY • Reported revenue of $7.88M up 166.66% YoY • Cue Biopharma, Inc. believes that its cash and cash equivalents on hand as of June 30, 2026, along with the net proceeds from the July 2026 private placement, will be sufficient.
0 · Reply
Relee187200
Relee187200 Aug. 14 at 8:07 PM
$CUE What happened after the close???
1 · Reply
daprinta
daprinta Aug. 14 at 2:18 PM
$CUE technically it’s shaping up to break a spread triple top@ $35.50-$36…& with a low&tight float count…this Cue-Ball cud have a meteoric move to triple digits on positive news/results‼️
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Aug. 11 at 3:11 AM
On this 10th day of August 2026 I purchased some $CUE about 5% of port. Good luck, ige differentiation is needed. Scientifically has a chance there are no guarantees in this business.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 10:49 PM
Cue Biopharma, Inc. $CUE (8h) Bullish Flow: Retail paper is getting shaken out while heavy-pocketed buyers scoop every dip along the lower trendline. Big bids are stacking up at the floor, laying the foundation for a massive secondary expansion wave. 🐂 💧 Bull Key Level: $25.97 (Bull confirmation to smash local channel resistance and trigger a high-velocity squeeze) 🐂 🔥 Bear Key Level: $22.50 (Key structural floor and critical multi-week demand zone to defend) 🐻 ⚠️ Targets: $35.00 / $45.52 💰 🍺 Why: The 8-hour chart is coiling like a springboard right on top of a massive volume shelf. Holding $22.50 keeps this ascending wedge primed for a violent rip through $35.00 straight up to $45.52. #cue | #cuebiopharma | #healthcare | #stocktrading | #hovdid
1 · Reply
ajmrtxl
ajmrtxl Aug. 7 at 6:33 PM
$CUE 's latest data on SqueezeFinder
0 · Reply
jigsaw76
jigsaw76 Aug. 4 at 6:17 PM
$CUE easy $80+
0 · Reply
Latest News on CUE
Cue Biopharma Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 5 days ago

Cue Biopharma Quarterly report: Q2 2026


Cue Biopharma Earnings release: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 5 days ago

Cue Biopharma Earnings release: Q2 2026


Cue Biopharma Registration statement: Registration filing

Aug 12, 2026, 8:00 AM EDT - 7 days ago

Cue Biopharma Registration statement: Registration filing


Cue Biopharma appoints James Ahlers as CFO

2026-08-03T13:05:29.000Z - 16 days ago

Cue Biopharma appoints James Ahlers as CFO


Cue Biopharma Slides: Corporate presentation

Jul 17, 2026, 7:00 AM EDT - 4 weeks ago

Cue Biopharma Slides: Corporate presentation


Cue Biopharma Announces $50.0 Million Private Placement

Jul 9, 2026, 9:40 PM EDT - 5 weeks ago

Cue Biopharma Announces $50.0 Million Private Placement


Cue Biopharma Registration statement: Registration filing

Jun 18, 2026, 8:00 AM EDT - 2 months ago

Cue Biopharma Registration statement: Registration filing


Cue Biopharma Slides: FY 2026

Jun 3, 2026, 3:10 PM EDT - 2 months ago

Cue Biopharma Slides: FY 2026


Cue Biopharma Registration statement: Registration filing

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Cue Biopharma Registration statement: Registration filing


Cue Biopharma Transcript: EGM 2026

Jun 1, 2026, 9:00 AM EDT - 2 months ago

Cue Biopharma Transcript: EGM 2026


Cue Biopharma Proxy statement: Proxy filing

May 21, 2026, 8:00 AM EDT - 3 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cue Biopharma Quarterly report: Q1 2026


Cue Biopharma Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cue Biopharma Earnings release: Q1 2026


Cue Biopharma Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 3 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma trading resumes

2026-05-04T17:37:20.000Z - 3 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-05-04T17:31:09.000Z - 3 months ago

Cue Biopharma trading halted, volatility trading pause


Why Is Cue Biopharma Stock Up Today?

2026-05-01T12:53:12.000Z - 3 months ago

Why Is Cue Biopharma Stock Up Today?


Cue Biopharma appoints Shao-Lee Lin as CEO

2026-04-30T21:13:55.000Z - 3 months ago

Cue Biopharma appoints Shao-Lee Lin as CEO


Cue Biopharma announces $30M private placement

2026-04-30T21:04:54.000Z - 3 months ago

Cue Biopharma announces $30M private placement


Cue Biopharma Announces $30 Million Private Placement

Apr 30, 2026, 4:25 PM EDT - 3 months ago

Cue Biopharma Announces $30 Million Private Placement


Cue Biopharma trading halted, volatility trading pause

2026-04-28T13:54:10.000Z - 4 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading resumes

2026-04-28T13:48:36.000Z - 4 months ago

Cue Biopharma trading resumes


Cue Biopharma trading resumes

2026-04-27T14:37:18.000Z - 4 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-04-27T13:47:34.000Z - 4 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading resumes

2026-04-24T13:48:28.000Z - 4 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-04-24T13:37:14.000Z - 4 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading halted, news pending

2026-04-23T23:50:37.000Z - 4 months ago

Cue Biopharma trading halted, news pending


Cue Biopharma Announces 1-for-30 Reverse Stock Split

Apr 22, 2026, 8:37 AM EDT - 4 months ago

Cue Biopharma Announces 1-for-30 Reverse Stock Split


Cue Biopharma Transcript: AGM 2026

Apr 13, 2026, 9:00 AM EDT - 4 months ago

Cue Biopharma Transcript: AGM 2026


Cue Biopharma Transcript: R&D Day 2026

Apr 7, 2026, 10:00 AM EDT - 4 months ago

Cue Biopharma Transcript: R&D Day 2026


Cue Biopharma Slides: FY 2026

Apr 7, 2026, 10:00 AM EDT - 4 months ago

Cue Biopharma Slides: FY 2026


Cue Biopharma Announces CEO Transition

Mar 27, 2026, 4:05 PM EDT - 5 months ago

Cue Biopharma Announces CEO Transition


Cue Biopharma Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026


Cue Biopharma Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Registration statement: Registration Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma Registration statement: Registration Filing


Cue Biopharma Annual report: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Annual report: Q4 2025


Cue Biopharma Earnings release: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Earnings release: Q4 2025


Cue Biopharma Annual report: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Annual report: Q4 2025


Cue Biopharma Proxy statement: Proxy Filing

Mar 6, 2026, 7:00 AM EST - 5 months ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Announces Pricing of $10 Million Public Offering

Dec 19, 2025, 8:00 AM EST - 8 months ago

Cue Biopharma Announces Pricing of $10 Million Public Offering


Cue Biopharma Announces Proposed Public Offering

Dec 18, 2025, 4:02 PM EST - 8 months ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Cue Biopharma Earnings release: Q3 2025


Cue Biopharma Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Cue Biopharma Quarterly report: Q3 2025


Cue Biopharma Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Quarterly report: Q2 2025


Cue Biopharma Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Earnings release: Q2 2025


Cue Biopharma Proxy statement: Proxy Filing

May 27, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Transcript: Status Update

May 15, 2025, 11:00 AM EDT - 1 year ago

Cue Biopharma Transcript: Status Update


Cue Biopharma Earnings release: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Earnings release: Q1 2025


Cue Biopharma Quarterly report: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Quarterly report: Q1 2025


Cue Biopharma to Host Virtual Investor Event on May 15, 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma to Host Virtual Investor Event on May 15, 2025


Cue Biopharma Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Transcript: Status Update

Apr 15, 2025, 4:30 PM EDT - 1 year ago

Cue Biopharma Transcript: Status Update


Cue Biopharma to Host Business Update Call and Webcast

Apr 14, 2025, 5:02 PM EDT - 1 year ago

Cue Biopharma to Host Business Update Call and Webcast


Cue Biopharma Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings release: Q4 2024

Mar 31, 2025, 12:00 AM EDT - 1 year ago

Cue Biopharma Earnings release: Q4 2024


Cue Biopharma Annual report: Q4 2024

Mar 31, 2025, 12:00 AM EDT - 1 year ago

Cue Biopharma Annual report: Q4 2024


Cue Biopharma Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 1:15 PM EST - 1 year ago

Cue Biopharma Transcript: Stifel 2024 Healthcare Conference


Cue Biopharma Announces Strategic Organizational Transition

Nov 14, 2024, 8:00 AM EST - 1 year ago

Cue Biopharma Announces Strategic Organizational Transition


Cue Biopharma Earnings release: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Cue Biopharma Earnings release: Q3 2024


Cue Biopharma Quarterly report: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Cue Biopharma Quarterly report: Q3 2024


Cue Biopharma Announces Proposed Public Offering

Sep 26, 2024, 11:10 PM EDT - 2 years ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma Proxy statement: Proxy Filing

Sep 10, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Aug 28, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings Call Transcript: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings Call Transcript: Q2 2024


Cue Biopharma Quarterly report: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Quarterly report: Q2 2024


Cue Biopharma Earnings release: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q2 2024


Cue Biopharma Proxy statement: Proxy Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Quarterly report: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Cue Biopharma Quarterly report: Q1 2024


Cue Biopharma Earnings release: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q1 2024


Cue Biopharma Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings Call Transcript: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings Call Transcript: Q4 2023


Cue Biopharma Earnings release: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q4 2023


Cue Biopharma Annual report: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Annual report: Q4 2023


daprinta
daprinta Aug. 18 at 7:48 PM
$CUE been nibbling on more stocks on dips in this $25 range…story is status quo…the rip will be worth owning & this will move like it’s hairs on fire
0 · Reply
Relee187200
Relee187200 Aug. 18 at 3:38 PM
$CUE Pitiful
0 · Reply
tealeaves
tealeaves Aug. 17 at 6:26 PM
$CUE today’s decline is consistent with profit-taking + anticipation of PIPE-share liquidity + low-float volatility than with deterioration in the underlying clinical story. The CEO transaction may add some headline pressure, but because it was tax-related, I consider it secondary to the 1.5M-share resale registration from July’s $50M PIPE (cost basis of which was $33.21/share). I’ll add to my position on dips below $25.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 14 at 8:14 PM
$CUE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$24.14 down -804.12% YoY • Reported revenue of $7.88M up 166.66% YoY • Cue Biopharma, Inc. believes that its cash and cash equivalents on hand as of June 30, 2026, along with the net proceeds from the July 2026 private placement, will be sufficient.
0 · Reply
Relee187200
Relee187200 Aug. 14 at 8:07 PM
$CUE What happened after the close???
1 · Reply
daprinta
daprinta Aug. 14 at 2:18 PM
$CUE technically it’s shaping up to break a spread triple top@ $35.50-$36…& with a low&tight float count…this Cue-Ball cud have a meteoric move to triple digits on positive news/results‼️
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Aug. 11 at 3:11 AM
On this 10th day of August 2026 I purchased some $CUE about 5% of port. Good luck, ige differentiation is needed. Scientifically has a chance there are no guarantees in this business.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 10:49 PM
Cue Biopharma, Inc. $CUE (8h) Bullish Flow: Retail paper is getting shaken out while heavy-pocketed buyers scoop every dip along the lower trendline. Big bids are stacking up at the floor, laying the foundation for a massive secondary expansion wave. 🐂 💧 Bull Key Level: $25.97 (Bull confirmation to smash local channel resistance and trigger a high-velocity squeeze) 🐂 🔥 Bear Key Level: $22.50 (Key structural floor and critical multi-week demand zone to defend) 🐻 ⚠️ Targets: $35.00 / $45.52 💰 🍺 Why: The 8-hour chart is coiling like a springboard right on top of a massive volume shelf. Holding $22.50 keeps this ascending wedge primed for a violent rip through $35.00 straight up to $45.52. #cue | #cuebiopharma | #healthcare | #stocktrading | #hovdid
1 · Reply
ajmrtxl
ajmrtxl Aug. 7 at 6:33 PM
$CUE 's latest data on SqueezeFinder
0 · Reply
jigsaw76
jigsaw76 Aug. 4 at 6:17 PM
$CUE easy $80+
0 · Reply
theivanhoff
theivanhoff Aug. 2 at 8:24 PM
0 · Reply
Relee187200
Relee187200 Jul. 31 at 3:45 PM
$CUE Why down today? Any news?
0 · Reply
jigsaw76
jigsaw76 Jul. 30 at 10:23 PM
$CUE WTF IS THIS SHIT IM CRASHING OUT DO SOMZTHING SHITSTAIN SHITSTOCK
0 · Reply
jigsaw76
jigsaw76 Jul. 23 at 10:48 AM
$CUE this ticker needs more attention
0 · Reply
daprinta
daprinta Jul. 21 at 9:52 PM
$CUE …nah…Sir Douche-bag11…ur shot & ur fired…I’ll sell u a small piece of my stock @ $60 & u’ll thx me;capiche!!!
1 · Reply
daprinta
daprinta Jul. 21 at 12:02 PM
$CUE conventional wisdom is not applicable here… The smartest and largest shareholders are extremely confident & will not sell a single share @ these levels…now…w/far less shares outstanding & ..a float that is owned/controlled …there’s virtually only 1way2 go☝️
0 · Reply
daprinta
daprinta Jul. 21 at 11:50 AM
$CUE be very careful…”plenty of room to go down”…how about unlimited upside that will be fueled by ppl/U…scrabbling to buyback…thus, the proverbial; SHORT SQUEEZE! Fair warning to brace yourself
1 · Reply
jigsaw76
jigsaw76 Jul. 20 at 11:06 PM
$CUE went all in
0 · Reply
jigsaw76
jigsaw76 Jul. 20 at 5:56 PM
$CUE need a big shot to tweet about this and bring in some volume, easy 2x
0 · Reply
AC_TRADER
AC_TRADER Jul. 20 at 3:35 PM
$CUE Some lvls t I made with @TrendSpider https://share.trendspider.com/chart/CUE/7594tdyr75
0 · Reply
jigsaw76
jigsaw76 Jul. 17 at 5:47 PM
0 · Reply